Trinity Biotech PLC ADR | Cash Flow
Fiscal year is January-December. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Net Income before Extraordinaries
9,652.60
16,952.20
21,678.70
100,333.40
40,686.10
22,066.20
Depreciation, Depletion & Amortization
3,592.40
4,426.60
5,611.60
6,114.20
5,252.70
4,116.60
Other Funds
7,160.90
1,041.90
9,989.00
101,496.00
40,270.90
28,055.80
Funds from Operations
20,405.90
20,336.90
17,301.40
7,276.80
4,837.50
10,106.10
Changes in Working Capital
11,042.50
4,522.20
6,402.40
1,665.20
139.40
7,383
Net Operating Cash Flow
9,363.40
15,814.70
10,899.00
5,611.70
4,698.10
2,723.10
Capital Expenditures
23,191.80
27,333.80
26,442.90
20,702.80
15,223.70
Sale of Fixed Assets & Businesses
1,408.00
-
-
-
-
Net Investing Cash Flow
61,234.70
27,333.80
27,548.90
21,811.60
16,347.20
Cash Dividends Paid - Total
4,376.00
4,952.50
5,071.60
-
-
Issuance/Reduction of Debt, Net
-
-
111,277.90
281.20
246.50
Net Financing Cash Flow
798.50
1,405.30
109,127.50
8,729.60
8,126.10
Net Change in Cash
52,665.80
13,014.00
92,351.30
24,772.00
19,703.50
Free Cash Flow
4,871.30
7,670.50
3,843.20
1,408.90
191.00
Net Assets from Acquisitions
39,450.90
-
-
-
-
Change in Capital Stock
3,577.40
3,547.20
2,921.20
8,448.40
7,879.60
Exchange Rate Effect
4.00
89.60
126.30
157.50
71.70
Other Uses
-
-
1,106.00
1,108.80
1,123.50
About Trinity Biotech
View Profile
